Condition
Lyme Neuroborreliosis
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00138801Phase 3CompletedPrimary
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT04577053Not ApplicableTerminated
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
NCT01635530Phase 4CompletedPrimary
Study of Lyme Neuroborreliosis
NCT03820999Not ApplicableUnknownPrimary
An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay
NCT00037479Phase 2Completed
Brain Imaging and Retreatment Study of Persistent Lyme Disease
Showing all 5 trials